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Abstract
To understand the hormonal coordination of the antagonism between molting and reproduction
in crustaceans, the terminally anecdysial mature female Callinectes sapidus was used as a model. The
regulatory roles of crustacean hyperglycemic hormone (CHH) and molt-inhibiting hormone (MIH)
in vitellogenesis were examined. A competitive specific RIA was used to measure the levels of MIH
and CHH in the hemolymphs of mature females at pre- and mid- vitellogenic stages, and their
effects on vitellogenesis at early (early 2, E2) and mid vitellogenesis (3) stages were determined in
vitro. A hepatopancreas fragments incubation system was developed and the levels of vitellogenin
(VtG), as well as VtG mRNA and heterogeneous nuclear (hn)VtG RNA were determined using RIA or
QPCR, respectively. MIH titers were four times higher at mid-vitellogenesis than at pre-
vitellogenesis, while CHH levels in the hemolymph were constant. In the in vitro incubation
experiments, MIH increased both VtG mRNA levels and secretion at ovarian stage 3. At stage E2,
however, MIH resulted in a mixed response: downregulation of VtG mRNA and upregulation of
hnVtG RNA. CHH had no effect on any of the parameters. Actinomycin D blocked the stimulatory
effects of MIH in stage 3 animals on VtG mRNA and VtG, while cycloheximide attenuated only VtG
levels, confirming the MIH stimulatory effect at this stage. MIH is a key endocrine regulator in the
coordination of molting and reproduction in the mature female C. sapidus, which simultaneously
inhibits molt and stimulates vitellogenesis.
Background
It has been proposed in decapod crustaceans that the high
energy demanding processes of molting and reproduction
are mutually antagonistic and do not occur simultane-
ously [1]. The antagonism is clearly demonstrated in the
female Callinectes sapidus: molting and reproduction occur
in two distinctive life phases with molting cycles occurring
only in the juvenile phase and ovarian development and
spawning cycles occurring only in adulthood.
Ovarian development is a major reproductive process,
during which oocytes grow as a result of vitellogenin pro-
duction and its accumulation in the form of yolk protein
(vitellin) and other cytoplasmic egg proteins in the
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oocytes [2]. In C. sapidus, vitellogenesis occurs primarily
in the hepatopancreas after terminal/pubertal molt and
requires a relatively short duration of 8–12 weeks for com-
pletion [3].
The phenomenon of reproductive phase accompanied by
terminal anecdysis (halt of molting cycles) is found in
only a few decapod crustaceans, including Maja squinado,
Libinia emarginata, and Chionoecetes bairdi [4-7]. Most of
these anecdysial animals are characterized by a degener-
ated molting gland, the Y-organ (YO), and the resulting
low levels of molting hormones (ecdysteroids) in the
hemolymph [8]. However, the adult C. sapidus female is
distinguished from these animals by having non-degener-
ated YO's, which retain their normal size and their capa-
bility to bind and respond to molt-inhibiting hormone
(MIH) by elevation of cyclic GMP (cGMP). Furthermore,
eyestalk ablation (the removal of the source for MIH)
induces molting in adult C. sapidus females [9], indicating
that the YO's also preserve their steroidogenic potential.
Taken together, unlike other anecdysial crustacean spe-
cies, molting cycle in the mature female C. sapidus is tem-
porarily arrested at intermolt stage, in synchrony with the
reproductive phase. Since to date the neuroendocrine
mechanism underlying these antagonistic processes has
not been examined in any crustacean species, the mature
C. sapidus female with its distinctive separate molting and
reproductive phases, serves as an excellent model species
to address the issue.
Molting and reproduction are regulated by the eyestalk
derived crustacean hyperglycemic hormone (CHH) fam-
ily [10,11] including CHH, MIH, mandibular organ-
inhibiting hormone (MOIH) [12], and gonad/vitellogen-
esis-inhibiting hormone (G/VIH) [13,14]. These neu-
ropeptides are synthesized in specific neurosecretory cells
of the medullar terminalis X-organ (XO), stored, and
released from the sinus gland (SG) in the eyestalk ganglia
(XOSG complex). The names of these neuropeptides usu-
ally refer to their primary functions or structural affiliation
to either CHH or MIH subfamilies.
CHH and MIH exist in different combinations and
number of isoforms depending on the species. Multiple
isoforms are found in the XOSG of penaeids, crayfish, and
lobsters [15], whereas in crab species only two isoforms of
CHH and one of MIH are detected [16-19]. Moreover,
CHH neuropeptides are characterized by pleiotropicity
and are usually involved in the regulation of several phys-
iological processes including molting, reproduction,
osmoregulation, energy metabolism, and stress response
[20].
Molting is controlled by CHH and MIH. High circulating
levels of these neuropeptides suppress synthesis and secre-
tion of ecdysteroids from the YO's by down-regulating
protein synthesis [21,22] which in turn leads to low titers
of ecdysteroids in the hemolymph [7,23-25]. Reproduc-
tion on the other hand is regulated both negatively and
positively by CHH family neuropeptides. The inhibition
is exerted by VIH in the eyestalk ganglia [14,26,27], and
its presence has been described in a few lobster species
[28-31], Litopenaeus vannamei [32], and the isopod Arma-
dillidium vulgare [33]. Vitellogenesis-stimulating hormone
(VSH), identified as an isoform of MIH in the sand
shrimp, Metapenaeus ensis [34], positively regulates vitell-
ogenesis. In addition to the XOSG, it is expressed in the
ventral nerve cord, thoracic ganglia, and brain. This find-
ing implies that a MIH like neuropeptide may be involved
in the regulation of reproduction.
Considering the roles of CHH and MIH in molting and
MIH isoform action as a VSH, we aimed to understand
how the antagonism between molting and reproduction
is hormonally coordinated in the terminally anecdysial
female C. sapidus. Our earlier study showed that like other
crab species, only one form of MIH is identified in the
XOSG of C. sapidus [35] and MIH mRNA [36]. In addition,
we found no evidence of a MIH, MIH-like neuropep-
tide(s) or its mRNA in the thoracic ganglia or brain of the
adult female (unpublished data). We therefore hypothe-
sized that XOSG derived CHH or MIH actively inhibit
molting in the female C. sapidus, while allowing reproduc-
tive processes to take place. Specifically, we questioned if
MIH or CHH have a role in the regulation of vitellogenesis
of C. sapidus. To address these questions, we first deter-
mined the hemolymph circulating concentrations of MIH
and CHH and their mRNA levels in the XO of mature
female C. sapidus. We also carried out in vitro studies on
hepatopancreas tissue fragments to identify the regulatory
roles of MIH and CHH in vitellogenesis, specifically at the
levels of VtG mRNA, VtG protein and heterogeneous nuclear
(hn) VtG RNA. Measuring hnVtG RNA provided an addi-
tional tool to examine transcription. We report that MIH
has a regulatory role in vitellogenesis in the female C. sap-
idus, while CHH seems to have no clear involvement. Spe-
cifically, MIH upregulated VtG mRNA, hnVtG RNA and
VtG secretion in heptopancreas fragments in vitro in the
advanced vitellogenic stage. Interestingly, MIH downreg-
ulated VtG mRNA, upregulated hnVtG RNA and had no
effect on VtG secretion in the early vitellogenic stage.
Results
MIH and CHH titers in the hemolymph of reproductive 
females
Neuropeptides in the hemolymph were determined by
specific radioimmunoassay (RIA) in 10 females at ovarian
stages 1 and 3, representing pre-vitellogenic and mid-
vitellogenic stages, respectively. The results showed a sig-
nificant four- fold increase in MIH levels at ovarian stageSaline Systems 2009, 5:7 http://www.salinesystems.org/content/5/1/7
Page 3 of 11
(page number not for citation purposes)
3 (19.6 fmol/ml) compared to stage 1 (5.7 fmol/ml) (Fig.
1Aa). CHH levels did not differ between the stages and
ranged between 130 and 150 ± 49 fmol/ml which are ~6
– 20 times higher than those of MIH (Fig. 1Ab). MIH and
CHH mRNA levels in the XO of mature females at the
same stages did not significantly differ and were 1500–
2500 copies/20 ng total RNA for MIH and 15000–40000
copies/20 ng total RNA for CHH (Figs. 1Ba and 1Bb).
Accordingly, the concentrations of ecdysteroids in the
hemolymph of these females were low at ovarian stages 1
and 3: 7 to 5 ng/ml, respectively (not shown).
In vitro incubation of hepatopancreas fragments
The effects of sinus gland neuropeptides (CHH and MIH) on VtG 
expression and secretion
To establish an in vitro bioassay, a preliminary experiment
was conducted to determine the effect of incubation
period on the stability of total RNA and VtG mRNA as well
as the optimal incubation time and dose of neuropeptides
for hepatopancreas fragments in vitro. The stability of RNA
was tested by visualization of the total RNA, determined
by the integrity of 18 S and 28 S ribosomal(r) RNA subu-
nits of the hepatopancreas extracted immediately after
dissection (t = 0 point) and after a 6 h incubation. The
results presented in additional file 1 show that 18 S and
28 S rRNA bands remained stable and similar to that of t
= 0 point after the 6 h incubation. The levels of VtG mRNA
were further tested by quantitative PCR (QPCR) analysis
on hepatopancreas fragments incubated in plain media.
Levels were found to be constant during the incubation
period (Fig. 2A).
The effect of different doses of CHH or MIH on VtG
mRNA was determined by incubating hepatopancreas
fragments of stage (early 2) E2 animals for 1 or 6 h. At 1 h
incubation, MIH at 0.05, 0.2 and 2 nM concentrations
MIH and CHH levels in the hemolymph and mRNAs in the XO of pre- and mid-vitellogenic females (ovarian stage 1 and 3) Figure 1
MIH and CHH levels in the hemolymph and mRNAs in the XO of pre- and mid-vitellogenic females (ovarian 
stage 1 and 3). A) hemolymph titers and B) mRNA a) MIH, b) CHH. MIH and CHH neuropeptides in the hemolymph were 
extracted with 40% isopropanol for the extraction of CHH and 60% isopropanol for the extraction of MIH followed by a spe-
cific RIA in 10 females at each stage 1 or 3. MIH and CHH mRNA levels were determined using QPCR in 17 females at stage 1 
and 21 females at stage 3 and are presented as copies/20 ng total RNA. Results are presented as mean ± SEM (N = 10). **, = P 
≤ 0.01.
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had no effect, however 5 nM resulted in a non-statistically
significant decrease of 25% of control in VtG mRNA. Dur-
ing the 6 h incubation, the effect was more pronounced,
although still statistically insignificant due to the low N
number (N = 3). MIH at 0.2, 2, and 5 nM showed a trend
of dose dependent effect, where VtG  mRNA levels
dropped to 62%, 62%, and 51% of the control, respec-
tively (Fig. 2B). CHH at 0.5, 5, and 20 nM showed no dif-
ference from control on VtG mRNA levels at both 1 and 6
h incubation (Fig. 2C). Based on these results, the subse-
quent in vitro experiments were carried out at 6 h incuba-
tion, unless specified otherwise.
The effects of CHH and MIH on vitellogenesis were fur-
ther examined on hepatopancreas of females at early and
mid-vitellogenic stages (E2 and 3, respectively). CHH (20
nM) significantly reduced VtG mRNA levels by 20% (N =
21) of control at E2 and had no effect at stage 3 (N = 6)
(Fig. 3Ab). MIH however, revealed a stage dependent
response. MIH (2 nM) reduced VtG mRNA levels in the
hepatopancreas of females at E2 by 60% (N = 21), but
caused an increase at stage 3 (N = 6) (Fig. 3Aa). The effect
of MIH on VtG secretion from hepatopancreas fragments
was stage dependent: at E2, no change was detected (N =
6), while at stage 3, MIH increased the levels of VtG in the
media to 204 ± 34% over the control (N = 5) (Fig. 3Ba).
CHH had no significant effect on VtG secretion at E2 and
3 stages (N = 5)(Fig. 3Bb).
To clarify the results obtained for stage E2, the effect of
CHH and MIH on VtG transcription was also tested on de
novo synthesis of VtG mRNA by measuring heterogeneous
nuclear RNA of VtG (hnVtG RNA). The levels of hnVtG
RNA increased to 270% over the control with MIH,
whereas CHH had no effect after a 1 h incubation. This
effect disappeared at the 2 h incubation period (N = 3)
(Fig. 4A). Since a difference in hnVtG RNA was only meas-
urable at the 1 h but not 2 h incubation, experiments test-
ing hnVtG RNA were set for 1 h. In a larger scale set of
experiments with a 1 h incubation, MIH caused a ~2.5
fold increase (256 ± 86%) in hnVtG RNA levels in the
hepatopancreas of females at E2, while CHH had no effect
(N = 11) (Fig. 4B).
The effects of co-incubation of actinomycin D and cycloheximide with 
MIH on VtG expression and VtG production
To test whether the changes in VtG secretion by MIH is
associated with its impact on VtG mRNA, hepatopancreas
fragments of females at ovarian stage 3 were co-incubated
with 2 nM MIH and a transcription inhibitor (actinomy-
cin D) or a translation inhibitor (cycloheximide). These
inhibitors were tested at two different concentrations: 0.5
and 10 μM. MIH increased VtG levels by 51% compared
to the control and MIH + 0.1% v/v EtOH increased by
45% (N = 5). Actinomycin D at 0.5 and 10 μM, in the
presence of MIH, reduced VtG levels to 60% and 49% of
MIH treatment, respectively (Fig. 5A), which were similar
to the media control. MIH + 10 μM AD decreased VtG
mRNA to 51% of MIH treatment (Fig. 5B).
Cycloheximide at 0.5 and 10 μM co-incubated with MIH
(+ EtOH), reduced VtG levels to ~35% of MIH (+ EtOH)
Evaluation and optimization of the hepatopancreas incubation  experiment Figure 2
Evaluation and optimization of the hepatopancreas 
incubation experiment. A) Incubation period had no 
effect on the stability of VtG mRNA in hepatopancreas frag-
ments of females at early ovarian stage 2 (E2). Bars, normal-
ized VtG mRNA; dashed line, total RNA. MIH had a more 
pronounced decreasing effect on VtG mRNA levels than 
CHH (0 – 20 nM) in hepatopancreas fragments of females at 
E2 incubated for 1 and 6 h, B) Incubation with 0 to 5 nM MIH 
and C) Incubation with 0 to 20 nM CHH. circles, 1 h incuba-
tion; squares, 6 h incubation. Data are presented as mean ± 
SEM (N = 3).
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and ~54% of the media control, but had no effect on VtG
mRNA levels (Fig. 6A and 6B). HnVtG RNA was not meas-
ured in this particular set of experiments as a different
experimental setup is required (i.e., 1 h incubation time,
see Fig. 4A).
The effect of other sinus gland factors on VtG mRNA levels
The pooled HPLC fractions of sinus-glands (SG) from
stage 3 vitellogenic females without CHH, MIH, and crus-
tacean hyperglycemic hormone precursor related- peptide
(CPRP) were tested using an in vitro hepatopancreas incu-
bation to determine whether other sinus gland-derived
substances had an effect on VtG expression. No effect was
found with 5% and 25% of SG equivalent (minus CHH,
MIH, and CPRP) on VtG expression in the hepatopancreas
fragments (Fig. 7). CPRP was also tested, as it is one of the
three major neuropeptides in the SG. CPRP fraction at 5%
and 25% SG equivalents and purified native CPRP at 25
nM showed no significant effect on VtG  expression
(Fig. 7).
Discussion
The present study aimed to gain a better understanding of
how XOSG derived neuropeptides regulate the antago-
nism between vitellogenesis and molting in the terminally
anecdysial mature female C. sapidus. We determined the
titers of CHH and MIH in the hemolymph of mature
females at different vitellogenic stages and tested their
effect on vitellogenesis, in vitro. Hemolymph titers of
CHH in these females were comparable to those meas-
ured in juvenile animals [35] and remained unchanged at
ovarian stages 1 and 3. However, the detection of MIH in
MIH stimulates VtG expression and secretion in hepatopancreas of females at ovarian stage 3 and downregulates VtG mRNA at  stage early 2 (E2) while CHH shows no significant effect Figure 3
MIH stimulates VtG expression and secretion in hepatopancreas of females at ovarian stage 3 and downregu-
lates VtG mRNA at stage early 2 (E2) while CHH shows no significant effect. A) VtG mRNA and B) VtG in the 
medium. a) 2 nM MIH treatment and b) 20 nM CHH treatment. The effects on VtG mRNA and protein secretion were tested 
in females at E2 (N = 21 and N = 6, respectively) and stage 3 (N = 6 and N = 5, respectively). Results are presented as mean ± 
SEM of % of control. * = P ≤ 0.05; *** = P ≤ 0.001.Saline Systems 2009, 5:7 http://www.salinesystems.org/content/5/1/7
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the hemolymph of mature females was initially surprising
considering they ceased molt. Hemolymph MIH levels at
mid-vitellogenic ovarian stage 3 were four times higher
than those of stage 1 (Fig. 1A), implying a putative role for
MIH in vitellogenesis. MIH and CHH mRNA levels were
statistically indifferent in both ovarian stages, with MIH
exhibiting high variation within each group (Fig. 1B).
These results indicate that the expression level of these
neuropeptides is not correlated with their secretion from
the SG, as shown in other studies [22,36].
The in vitro hepatopancreas fragments incubation system
was used to further determine whether circulating CHH
and MIH play a regulatory role in vitellogenesis in C. sap-
idus [5,27,28,32,34,37,38]. Their effect was tested at the
levels of VtG gene transcription by measuring changes in
VtG  mRNA levels, and VtG translation, determined by
changes in VtG secretion as this protein does not accumu-
late in the hepatopancreas but is being secreted immedi-
ately following translation [3]. CHH had no consistent
effects on vitellogenesis: it decreased VtG mRNA by 20%
only at stage E2 and had no effect on VtG secretion at both
E2 and 3 stages (Figs. 3Ab and 3Bb). However, with MIH
treatment, both VtG mRNA and VtG protein levels exhib-
ited different responses at the two ovarian stages tested.
While  VtG  mRNA decreased at stage E2, it slightly
increased at stage 3 in response to MIH (Fig. 3Aa). VtG
secretion did not differ from control treatment at stage E2
but increased at stage 3 (Fig. 3Ba). These results imply that
MIH may have an inhibitory role at early ovarian stages,
MIH upregulates hnVtG RNA in hepatopancreas of females at  ovarian stage E2 after 1 h incubation Figure 4
MIH upregulates hnVtG RNA in hepatopancreas of 
females at ovarian stage E2 after 1 h incubation. A) 
Changes in hnVtG RNA were measured after 1 h or 2 h incu-
bation with either 20 nM CHH (black bars) or 2 nM MIH 
(grey bars) and are measurable only at 1 h incubation period 
(N = 3). B) hnVtG RNA change in response to 20 nM CHH or 
2 nM MIH (N = 11). Results are presented as mean ± SEM of 
% of control. * = P ≤ 0.05; ** = P ≤ 0.01.
Co-incubation of MIH and actinomycin D (AD) blocks the  increase of VtG protein (A) and VtG mRNA (B) in hepatopan- creas fragments of ovarian stage 3 females Figure 5
Co-incubation of MIH and actinomycin D (AD) 
blocks the increase of VtG protein (A) and VtG 
mRNA (B) in hepatopancreas fragments of ovarian 
stage 3 females. The concentration of MIH was 2 nM and 
those of actinomycin D were 0.5 and 10 μM. Results are pre-
sented as mean ± SEM of % of control (N = 5). The alphabet-
ical letters show the significant differences at P < 0.05.Saline Systems 2009, 5:7 http://www.salinesystems.org/content/5/1/7
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and a stimulatory role at mid ovarian stages. To determine
whether MIH indeed downregulates VtG gene transcrip-
tion at stage E2, we further tested the activation of VtG
gene by measuring the short-lived hnVtG  (= pre VtG
mRNA). The increase of hnVtG RNA levels in response to
MIH at this stage indicated that the VtG gene is activated
and thus its transcription is being enhanced (Fig. 4). These
results were corroborated by a different set of experiments
in which incubation of hepatopancreas fragments with
membrane permeable cyclic nucleotides at stage E2
resulted in the same response [39]. The reason for the con-
tradicting response of VtG mRNA and  hnVtG  RNA is
unclear and will require further study.
Stimulation of vitellogenesis by SG-MIH has not been
reported in decapod crustaceans, with the exception of
MIH-B in M. ensis [34]. To verify the stimulatory effect of
MIH on vitellogenesis at ovarian stage 3, actinomycin D
(a general inhibitor of eukaryotic transcription) and
cycloheximide (a general inhibitor of eukaryotic transla-
tion), were separately co-incubated with MIH. The addi-
tion of actinomycin D and cycloheximide to MIH
treatment resulted in a decrease to 60% and 35% of VtG
levels, respectively, compared to MIH alone (equivalent to
95% and 54% of control levels) (Figs. 5 and 6). Actinomy-
cin D co-incubated with MIH, decreased VtG mRNA levels
by 49%, indicating that the respective decrease in VtG lev-
els is likely to be a result of the reduced VtG transcription
(Fig. 5A). The decrease of VtG mRNA with MIH/actinomy-
cin D to control levels suggests pre-existing VtG mRNA in
the hepatopancreas fragments. Furthermore, cyclohex-
imide probably blocked the translation of the newly MIH
induced VtG mRNA as well as the pre-existing VtG mRNA,
resulting in lower levels of VtG protein compared to the
control. In addition, the unchanged levels of VtG mRNA
with MIH/cycloheximide imply that the transcription
Co-incubation of MIH and cycloheximide reversed the effect  of MIH on VtG protein (A) and had no effect on VtG mRNA  (B) Figure 6
Co-incubation of MIH and cycloheximide reversed 
the effect of MIH on VtG protein (A) and had no 
effect on VtG mRNA (B). The concentration of MIH was 2 
nM and those of cycloheximide were 0.5 and 10 μM. Results 
are presented as mean ± SEM of % of control (N = 5). The 
alphabetical letters show the significant differences at P < 
0.05.
Sinus gland extract (SGE) without the known neuropeptides  caused no change in VtG mRNA in hepatopancreas of stage 3  in vitro Figure 7
Sinus gland extract (SGE) without the known neu-
ropeptides caused no change in VtG mRNA in hepat-
opancreas of stage 3 in vitro. Hepatopancreas fragments 
were incubated with sinus gland extract from which CPRP, 
CHH, and MIH were removed (SGE(-)) at 25% and 5% sinus 
gland equivalent; CPRP HPLC fraction (CPRP F) at 25% and 
5% sinus gland equivalent; and at 25 nM CPRP. Control level 
is indicated by a dashed line and data are presented as mean 
± SEM (N = 5).Saline Systems 2009, 5:7 http://www.salinesystems.org/content/5/1/7
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machinery was not affected. Overall, these results demon-
strate that MIH stimulation occurs at transcription and
translation of VtG at ovarian stage 3.
Support evidence for MIH regulation in vitellogenesis is
provided by the appearance of specific binding sites for
MIH in the hepatopancreas of mature female C. sapidus.
The abundance of the binding site increased gradually
with ovarian development and was higher at stage 3 than
at stages 1 and 2 [39].
It is tacitly accepted that V/GIH inhibits vitellogenesis,
while vitellogenin/gonad-stimulating hormone (V/GSH)
enhances vitellogenesis processes. However, CHHs were
shown to inhibit general mRNA synthesis in the ovaries of
vitellogenic female Penaeus semisulcatus [40]. The few
cases reporting the decrease of VtG mRNA levels by V/GIH
and CHH have been shown in ovaries of immature
penaeid females [28,32,41]. Although these studies were
conducted on ovarian tissue and not hepatopancreas, they
support our finding of decreased VtG mRNA levels and
indicate that this effect may be more common at early
stages of ovarian development.
The observation that MIH positively regulates vitellogene-
sis at stage 3 is concordant with a previous report in which
the non SG-MIH isoform stimulated vitellogenesis in the
shrimp M. ensis [34]. The lack of MIH or MIH-like neu-
ropeptide in non-XOSG tissues of the female C. sapidus,
suggests that the vitellogenesis-stimulatory role is carried
out by the SG-MIH. To our knowledge, the current study
is the second description of the effect of MIH neuropep-
tide on VtG mRNA in the hepatopancreas of a mature
vitellogenic female crustacean.
In light of the mutual antagonism of molt and reproduc-
tion, the coordinated control of these two processes in
crustacean species that continue to molt after puberty may
require a complex regulatory system to allow both events
[1]. The control may be exerted by multiple CHH and
MIH isoforms, which indeed are found in non- crab spe-
cies such as penaeids, crayfish, and lobsters [15]. It also
can be controlled by pleiotropic neuropeptides in species
carrying only a few neuropeptide forms, such as C. maenas
[17,18] and Necora  (unpublished observation) that do
molt during their adulthood. Low ecdysteroid circulating
levels were also observed in another anecdysial crab, the
C. opillio [42], suggesting that terminal anecdysis is associ-
ated with remarkably low ecdysteroids levels (lower than
intermolt juveniles levels) in the hemolymph. Neverthe-
less, the two groups (terminally anecdysial or those that
molt during their adulthood) may differ only in the dura-
tion of the intermolt stage, i.e., extended intermolt period
in species like the female C. sapidus. Altogether, based on
the low ecdysteroid level in the hemolymph compared to
high MIH and CHH levels, and the potentially functional
YO, we conclude that the activity of the YO is suppressed
by MIH in the mature female C. sapidus. Furthermore, our
results suggest that the SG of adult female C. sapidus does
not contain another vitellogenic regulatory factor(s)
(Fig. 7).
Conclusion
The current study tested the possible regulatory roles of
SG-MIH, CHH and CPRP in vitellogenesis, in vitro. The
results show that MIH regulates vitellogenesis in a vitello-
genic stage dependent manner: MIH is stimulatory at the
levels of both transcription and translation of VtG at mid-
vitellogenesis but its effect seems different at early stages.
In light of the role of MIH in vitellogenesis, we infer that
MIH may play a dual role in females of crab species that
exhibit a terminal anecdysis upon sexual maturity in their
life cycle: maintaining intermolt, while regulating vitello-
genesis.
Methods
Animals
Female C. sapidus were captured in the Rhode River (a trib-
utary of the Chesapeake Bay, USA) transported in aerated
water, and held in recirculating 4.5 cubic meter tanks at
environmental conditions matching the Bay for 2–5 days
before dissection. Ovarian development was staged based
on ovarian weight and gamete size according to criteria
established previously [43]. Stage early 2 (E2) represents
C. sapidus MIH antibody demonstrates high and equal specifi- city to MIH and rMIH and does not cross react with CHH Figure 8
C. sapidus MIH antibody demonstrates high and equal 
specificity to MIH and rMIH and does not cross react 
with CHH. Standard curves of MIH, rMIH and CHH with 
MIH antibody. Neuropeptides at concentrations ranging from 
0.25 pM to 1 nM were applied to RIA using anti-MIH raised 
against rMIH produced in Drosophila S2 cells at 1:20,000 final 
dilution. Close circles- nMIH, open circles- rMIH, triangles- 
CHH. Inset- Parallelism of nMIH and diluted hemolymph 
tested by MIH RIA and shown in linear regressions. Close 
circles- nMIH, open circles- hemolymph.Saline Systems 2009, 5:7 http://www.salinesystems.org/content/5/1/7
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the beginning of vitellogenesis where oocyte size is small
and similar to those at stage 1, but vitellin (yellow in
color) starts to accumulate within the oocyte. This stage is
the earliest point of detecting both VtG mRNA and VtG
protein [3].
Batch purification and quantification of native CHH, 
native MIH, and recombinant MIH
Neuropeptides of sinus glands (SG) were purified using
RP-HPLC as described [44]. Amino acid analyses were car-
ried out for the quantification of the purified native MIH,
native CHH, and recombinant MIH (rMIH) using the o-
phthalaldehyde pre-column derivation method as
described [16].
CHH and MIH concentrations in the hemolymph
Hemolymph samples were collected and frozen at -20°C
until processed. Neuropeptides were extracted from 1 ml
hemolymph by adding isopropanol to 40% (v/v) for
CHH extraction followed by centrifugation at 2000 rpm
for 30 min at 4°C. The resulting pellet was re-extracted
with 60% isopropanol (for MIH extraction) and pelleted
as before. Supernatants were pooled and dried under vac-
uum (SpeedVac, Jouan) before being analyzed by RIAs as
described [45]. The antiserum used in MIH RIA was gen-
erated in rabbits (Proteintech Group Inc.) against recom-
binant MIH with a His Tag at its C terminus, produced in
an S2 Drosophila cell expression system. Both native [125I]
MIH and [125I] CHH were prepared using a chloramine-T
labeling method. [125I] MIH or [125I] CHH was separated
from free [125I] on a PD 10 column (GE Healthcare) as
described [16]. Specific activities were approximately
300–500 Ci/mmol. A standard curve of MIH RIA ranging
from 0.1–1000 fmol/tube was prepared with native MIH
and a final dilution of MIH antiserum at 1:20,000 (Fig. 8).
The sensitivity of typical MIH RIAs was between 1.2 10-12
and 2.5 × 10-11 M, with an ED50 value of 5.73 ± 0.02 × 10-
10 M (N = 3) and the detection limit of 1.2 × 10-12 M. A
serial dilution of hemolymph was run in parallel to the
native MIH (Fig. 8 insert). The detailed descriptions for
antiserum production and RIA of CHH were previously
provided [35]. The ED50 value of CHH was 4.00 ± 0.02 ×
10-10 M (N = 3). The RIA data were analyzed and plotted
using the SOFTMax PRO v1.2.0 software (Molecular
Devices).
Ecdysteroid Radioimmunoassay
Hemolymph samples (10 μl) were analyzed for the total
concentration of ecdysteroid using an Ecd-RIA with ecdys-
one specific antiserum and [3H] PoA (Perkin Elmer) and
Ecd antiserum, as described [18]. Ecdysone served as a
standard at concentrations ranging from 2.5 ng to 30 pg/
tube. The results were analyzed using the AssayZap pro-
gram (Biosoft) and the EC50 value of Ecd-RIA was 100 ±
10 pg/tube (n = 10).
Quantitative PCR (QPCR) analysis of VtG in the 
hepatopancreas and VtG ELISA
Total RNA was extracted using the RNeasy mini kit (Qiagen).
cDNA preparation and quantitative PCR (QPCR) analysis
were conducted using the procedure described for the meas-
urement of hepatopancreas VtG mRNA and with normaliza-
tion against arginine kinase [3]. HnVtG RNA was measured
by QPCR analysis using a pair of primers located in intron #1
of the vitellogenin gene based on a 1539 bp partial sequence
amplified from genomic DNA (GenBank accession number
EU293808): Forward primer –
5'GTTCCCTGCCTGGCTTCA3'; Reverse primer –
5'CGGCTGTCGAGGTGATTATGA3'. This partial VtG  gene
served as a template for the cRNA used in the standard curve.
To avoid genomic DNA amplification, total RNA was treated
with 1 unit/1 μg RQ1 DNase (Promega) prior to reverse tran-
scription, and the results obtained from cDNA amplification
were corrected by subtracting the levels of non-reverse tran-
scribed RNA amplification (no-RT control).
Vitellogenin levels in the incubation medium were deter-
mined by a competitive VtG ELISA. The media proteins
were precipitated with 60% ammonium sulfate prior to
the ELISA procedure as described [3]. When VtG levels
were measured in the tissues and media, both were
homogenized together in a "tissuelyser" (Qiagen) before
ammonium sulphate precipitation.
Incubation in vitro of hepatopancreas fragments with 
neuropeptides, actinomycin D or cycloheximide
Hepatopancreas tissue was removed from vitellogenic
females and washed in 10 volumes of ice-cold Medium-
199 medium (Sigma) (adjusted with NaCl to osmolarity
of 960 mmol/kg), with gentle agitation on ice for 2–3 h,
and 3 medium exchanges. Hepatopancreas fragments
(~10 mg each) were directly weighed into 400 μl medium
containing 100 μg/ml BSA, 1× protease inhibitors cocktail
for tissue culture (Sigma), and with or without the tested
neuropeptide in 24 well plates (Corning). The plates were
incubated at 23–24°C with gentle agitation for 6 h. To test
if other factors in the SG have roles in vitellogenesis, all
HPLC fractions of SG extracts were pooled excluding crus-
tacean hyperglycemic hormone precursor related peptide
(CPRP), CHH, and MIH, and were also examined.
To further define the specific action of MIH, hepatopancreas
fragments were exposed to actinomycin D (Sigma) or
cycloheximide (Research Products international Corp.) at a
final concentration of 0.5 and 10 μM in the presence of MIH.
The actinomycin D results were compared to those of MIH
treatment. The cycloheximide results were compared to
those of MIH + 0.1% v/v EtOH treatment, since EtOH was
used as a vehicle for this reagent. In these experiments, VtG
levels were measured in the medium and tissue and the
results were obtained as μg/mg total protein of both tissueSaline Systems 2009, 5:7 http://www.salinesystems.org/content/5/1/7
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and medium combined, before conversion into % of con-
trol. For the measurement of hnVtG RNA in the hepatopan-
creas, which indicates a de novo synthesis of newly
transcribed and unprocessed mRNA, and reflects the actual
transcription rates [46,47], incubation periods of 1 and 2 h
were initially compared. Consequently, a 1 h incubation
period was set for all experiments measuring hnVtG RNA.
In general, control treatments were tested in sextuplicate and
all other treatments in quadruplicates. At the end of the
experiment, the tissue fragments were frozen at -80°C until
further analyses for VtG mRNA and hnVtG RNA QPCR, as
described above. The results of several independent experi-
ments were pooled, compared, and converted to % of con-
trol due to high individual variations in VtG levels.
Statistical analysis
The data obtained from QPCR, RIA, and ELISA is pre-
sented as the mean ± SEM. The results were subjected to
GraphPad Instat 3 program (GraphPad Software). The
data were analyzed using one-way ANOVA followed by
Tukey-Kramer multiple comparison test. In all cases, a sta-
tistical difference was accepted at P ≤ 0.05.
Abbreviations
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